Utilization of deworming medication and its associated factors among pregnant married women in 26 sub-Saharan African countries: a multi-country analysis

Tropical Medicine and Health

Mpho Keetile¹  Abdul-Aziz Seidu²  Betregiorgis Zegeye³  Sanni Yaya⁴  Edward Kwabena Ameyaw⁵  Bright Opoku Ahinkorah⁵ 

[1] Department of Population Studies, Faculty of Social Sciences, University of Botswana, Private Bag, UB 0022, Gaborone, Botswana;Department of Population and Health, University of Cape Coast, PMB 0494, Cape Coast, Ghana;College of Public Health, Medical and Veterinary Sciences, James Cook University, 4811, Townsville, QLD, Australia;HaSET Maternal and Child Health Research Program, Shewarobit Field Office, Shewarobit, Ethiopia;School of International Development and Global Studies, Faculty of Social Sciences, University of Ottawa, 120 University Private, K1N 6N5, Ottawa, ON, Canada;The George Institute for Global Health, Imperial College London, London, UK;School of Public Health, Faculty of Health, University of Technology Sydney, 2007, Sydney, NSW, Australia;

关键词: Deworming;    DHS;    Factors;    Global health;    Pregnant women;    Sub-Saharan Africa;    Utilization;   

DOI  :  10.1186/s41182-021-00343-x

来源: Springer

【 摘 要 】

BackgroundDeworming is one of the strategies to reduce the burden of anemia among pregnant women. Globally, pregnant women in sub-Saharan Africa are more affected by anemia. Therefore, this study examined both the coverage and demographic, socioeconomic, and women empowerment-related factors associated with the utilization of deworming medication among pregnant married women in sub-Saharan Africa.MethodsWe used data from the most recent Demographic and Health Surveys of 26 countries in sub-Saharan Africa conducted between 2010 and 2019. Using Stata version-14 software, analysis was done on 168,910 pregnant married women. Bivariate and multivariable logistic regression analyses were conducted to examine the factors associated with the utilization of deworming medication. The results were presented using adjusted odds ratios (aORs) at 95% confidence intervals (CIs).ResultsThe pooled results showed that about 50.7% (95% CI 48.2–53.3%) of pregnant married women in the studied countries took deworming medications, and this varied from as high as 84.1% in Sierra Leone to as low as 2% in Angola. Regarding sub-regional coverage, the highest and lowest coverages were seen in East Africa (67.6%, 95% CI 66.0–69.1%) and West Africa (24.3%, 95% CI 22.4–26.4%) respectively. We found higher odds of utilization of deworming medication among older pregnant married women (aOR=1.93, 95% CI 1.32–2.84), women with educated husbands (aOR=1.40, 95% CI 1.11–1.77), wealthier women (aOR=3.12, 95% CI 1.95–4.99), women exposed to media (aOR=1.46, 95% CI 1.18–1.80), and those who had four or more antenatal care visits (aOR=1.51, 95% CI 1.24–1.83).ConclusionsEnhancing women’s education, disseminating information about maternal healthcare services through mass media, and ensuring that women from economically disadvantaged households benefit from national economic growth can be considered as deworming medication improvement strategies in sub-Saharan Africa. Moreover, providing more attention to adolescents or young pregnant women and increasing the number of antenatal care visits could be considered to increase deworming uptake among pregnant married women.

【 授权许可】

CC BY